Source: Pyrexar Medical Blog

Pyrexar Medical Blog Trilogy of Cancer Technologies at UMMC

The University of Maryland Medical Center offers a new Trilogy of Radiation Oncology program at their downtown Baltimore facility. The cancer center, first in the world to provide proton therapy and hyperthermia under one roof, offers the best in cancer treatment technologies to patients. With the addition of the Gammapod treatment system for early-stage breast cancer, the UMMC maintains it's standing as a leader in patient care.Pyrexar Medical is privileged to have its BSD-2000 Deep Regional Hyperthermia System and BSD-500 Superficial/Interstitial Hyperthermia System in the hands of these medical pioneers. Many advancements and best practices have come from the pioneering work of the Translational Radiation Science Team at the university.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Mark Falkowski's photo - CEO of Pyrexar Medical

CEO

Mark Falkowski

CEO Approval Rating

85/100

Read more